000989 Stock Overview
Provides traditional Chinese, chemical, biological, and health medicine products in China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Jiuzhitang Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.39 |
| 52 Week High | CN¥11.69 |
| 52 Week Low | CN¥6.10 |
| Beta | 0.49 |
| 11 Month Change | -1.54% |
| 3 Month Change | -3.62% |
| 1 Year Change | -41.16% |
| 33 Year Change | -26.72% |
| 5 Year Change | -22.45% |
| Change since IPO | -74.48% |
Recent News & Updates
Shareholder Returns
| 000989 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 0.8% | -0.7% | 0.4% |
| 1Y | -41.2% | -16.8% | -18.8% |
Return vs Industry: 000989 underperformed the CN Pharmaceuticals industry which returned -16.8% over the past year.
Return vs Market: 000989 underperformed the CN Market which returned -18.8% over the past year.
Price Volatility
| 000989 volatility | |
|---|---|
| 000989 Average Weekly Movement | 3.7% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 8.6% |
| 10% least volatile stocks in CN Market | 3.6% |
Stable Share Price: 000989 has not had significant price volatility in the past 3 months.
Volatility Over Time: 000989's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 3,519 | Xu Xiang Ping | www.hnjzt.com |
Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. The company offers Shuxuetong injections, Angong Niuhuang pills, Gastrodia Gouteng granules, Danxi granules, and Compound Jiangzhi tablets for cardiovascular and neurological treatment; Nudehua Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Analgesic capsules for the treatment in gynecology; Houyan pills for ear, nose, and throat (ENT) diseases; Jianwei Yuyang tablets for digestion; and prescription drug product systems, Jiaqi Ganxian granules, and Chidan Tuihuang granules for liver diseases. It also provides over the counter (OTC) drugs comprising blood-tonifying, cardiovascular and cerebrovascular, urinary system, pediatric, gynecologic, bone and muscles, respiratory system, dermatologic, nervous system, ENT, and digestive system products; and stem cell and other drugs.
Jiuzhitang Co., Ltd. Fundamentals Summary
| 000989 fundamental statistics | |
|---|---|
| Market cap | CN¥5.47b |
| Earnings (TTM) | CN¥257.13m |
| Revenue (TTM) | CN¥2.82b |
21.3x
P/E Ratio1.9x
P/S RatioIs 000989 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000989 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.82b |
| Cost of Revenue | CN¥1.19b |
| Gross Profit | CN¥1.63b |
| Other Expenses | CN¥1.37b |
| Earnings | CN¥257.13m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.30 |
| Gross Margin | 57.75% |
| Net Profit Margin | 9.11% |
| Debt/Equity Ratio | 7.7% |
How did 000989 perform over the long term?
See historical performance and comparison